Albert Labs International (FRA:VB50) EV-to-EBIT : (As of Jun. 25, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Albert Labs International's Enterprise Value is €1.02 Mil. Albert Labs International does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Albert Labs International's EV-to-EBIT at this moment.

The historical rank and industry rank for Albert Labs International's EV-to-EBIT or its related term are showing as below:

FRA:VB50' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.87 Med: 0 Max: 2.47
Current: 2.46

During the past 2 years, the highest EV-to-EBIT of Albert Labs International was 2.47. The lowest was -7.87. And the median was 0.00.

FRA:VB50's EV-to-EBIT is ranked better than
58.12% of 437 companies
in the Biotechnology industry
Industry Median: 8.79 vs FRA:VB50: 2.46

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Albert Labs International's Enterprise Value for the quarter that ended in Mar. 2023 was €0.00 Mil. Albert Labs International does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Albert Labs International's Earnings Yield (Joel Greenblatt) % at this moment.

Albert Labs International EV-to-EBIT Historical Data

The historical data trend for Albert Labs International's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International EV-to-EBIT Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

EV-to-EBIT

-0.64

Albert Labs International Semi-Annual Data
	Mar21	Mar22	Mar23
EV-to-EBIT	-	-5.32	-4.45

Competitive Comparison of Albert Labs International's EV-to-EBIT

For the Biotechnology subindustry, Albert Labs International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albert Labs International's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Albert Labs International's EV-to-EBIT falls into.

Albert Labs International EV-to-EBIT Calculation

Albert Labs International's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	1.023	/
	=

Albert Labs International (FRA:VB50) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Albert Labs International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 )	=	EBIT	/	Enterprise Value (Q: Mar. 2023 )
	=		/	0
	=	%

Albert Labs International EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Albert Labs International's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (FRA:VB50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (FRA:VB50) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

ABRT:Canada

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (FRA:VB50) Headlines

No Headlines